Small group health insurance premiums are expected to rise by 14% in 2027, driven by higher medical costs and increasing use of specialty drugs.

Small group health insurance premiums are poised for a significant increase in 2027, with insurers anticipating a median hike of 14%. This proposed increase reflects projections from nearly 300 insurers across all 50 states and the District of Columbia, as analyzed by the Peterson-KFF Health System Tracker. Such a rise can have far-reaching implications not just for small businesses, but for the broader healthcare system as well.
Current Premium Trends and Implications
This 14% figure marks an uptick from the 11% median requested for 2026, suggesting a troubling trend in cost management for small group plans. At a glance, these numbers might paint a bleak picture, but they represent a broader systemic issue regarding healthcare costs that are increasingly unsustainable. While these projections are preliminary and await regulatory review, they are based on actual pricing forecasts submitted by insurers to state regulators. This highlights an urgent need for benefits advisors to brace their clients for a challenging renewal season. If you're working in this space, takeaway: insurers are preparing for a turbulent environment, and clients need to be ready for potentially tough conversations ahead.
Contributing Factors to the Premium Increase
The driving force behind this premium surge is a combination of rising medical costs, increased service utilization, and escalating expenses related to specialty drugs. KFF detailed that the underlying medical trend—the interplay of price and utilization—stands at a median of 10.8% across a sample of 82 insurers, underscoring a deepening concern about healthcare affordability.
One particular area of this complexity involves GLP-1 medications, which are increasingly utilized for diabetes management. Although some plans have eliminated coverage for these drugs when used for weight loss, their overall costs continue to escalate due to higher usage among diabetes patients. Mass General Brigham Health Plan has expressed alarm at the uptick in prescriptions for these medications, which are being prescribed more frequently despite coverage limitations. The situation isn't solely about individual plans; it reflects wider trends in prescription drug use that resonate across the healthcare industry.
The financial impact of GLP-1 medications cannot be overstated. They now account for about 20% of total prescription spending among employer plans, up from 17.5% just a year ago, according to the State of Employee Benefits Report 2026 by Benefitfocus. Plan expenses for members using GLP-1 drugs average around $7,400 annually. (And this is the part most people overlook: these individual costs can dramatically shift the entire financial landscape for small businesses trying to keep healthcare affordable for their employees.)
Behavioral Health Spending and Market Dynamics
Behavioral health expenditures significantly contribute to the rising premiums, with Boston Medical Center Health Plan reporting annual growth exceeding 20% over the last two years. This surge is driven by increased service utilization paired with higher provider rates, which paints a worrying picture of unmet mental health needs leading to elevated costs. Blue Cross and Blue Shield of Massachusetts also noted a sharp escalation in spending, indicating that healthcare costs are rising at their fastest pace in over a decade. If you’re involved in this sector, prepare for an especially tight squeeze on budgets.
These cost dynamics coincide with a troubling trend in enrollment for fully insured small group plans, which has plummeted by roughly 41% from 2013 to 2024, dropping from 17 million to about 10 million enrollees. This decline is largely associated with healthier groups opting for level-funded arrangements. Consequently, this decision effectively leaves a sicker population in the fully insured market, which has a direct correlation to rising costs—pushing premiums even higher.
Preparing for the 2027 Renewal Cycle
Shifts towards level-funded plans have increased dramatically. These arrangements rose from 2% in 2021 to over 11% in 2025 in Massachusetts alone. KFF researchers caution that this migration could further erode the risk pool for fully insured small group plans, exacerbating future premium increases, particularly for small businesses with higher health risks. Here’s the thing: this trend could create a vicious cycle, where the remaining insured population is increasingly burdened by rising costs.
For benefits advisors, the impending 2027 renewal cycle necessitates a two-pronged strategy. First, clients must gain clarity on the underlying factors contributing to these significant rate increases. Transparency is key; understanding the “why” behind costs can demystify the process. Second, advisors must engage in intricate discussions about plan design. This involves balancing the trade-offs linked with level-funded or self-funded options against guaranteed renewals and ACA protections. Failure to do so may not only alienate clients but might also constrain their choices moving forward.
Advisors who successfully align plan structures with employee health profiles and articulate the implications of these decisions will be in a better position to navigate the complexities of upcoming renewal discussions. The stakes are high; the implications of these discussions will impact not just immediate costs but long-term employee health and well-being.
Future Outlook: Implications for the Healthcare System
The anticipated rise in small group health insurance premiums in 2027 signals broader challenges within the healthcare system that will likely resonate for years. If current trends continue, small businesses may find it increasingly difficult to provide health insurance, pushing some to reconsider their benefits strategies altogether. As the gap between available plans and employee needs widens, a potential exodus from fully insured plans could lead to significantly higher costs and lesser coverage for those who remain.
What this means for you is that understanding these trends is not merely intellectual. As premiums continue to rise, you should consider how health insurance structures affect not just individual businesses, but the workforce as a whole. The complexities of health costs are mounting, and navigating them requires foresight and adaptability. Policy adjustments may also be necessary to reconcile rising costs with accessible healthcare for all.
Discussion
Sign in to join the discussion.